Active substanceDextran [average molecular weight 30000-40000] + DextroseDextran [average molecular weight 30000-40000] + Dextrose
Similar drugsTo uncover
  • Rheopolyglucin with glucose
    solution locally d / infusion 
  • Dosage form: & nbspsolution for infusion and topical application
    Composition:

    Active substances: dextran [average molecular weight 30000-40000] 100 g, dextrose (in terms of anhydrous substance) 50 g;

    ancillary substance: water for injection up to 1 liter.

    Description:Transparent, colorless or slightly yellowish liquid.
    Pharmacotherapeutic group:plasma-substituting agent
    Pharmacodynamics:

    Blood substitute, increases the suspension stability of blood, reduces its viscosity, restores blood flow in small capillaries, normalizes arterial and venous circulation, prevents and reduces the aggregation of blood elements, exerts detoxification effect.

    By the osmotic mechanism it stimulates diuresis (it is filtered in the glomeruli, creates high oncotic pressure in the primary urine and prevents the reabsorption of water in the tubules), which promotes (and accelerates) the release of poisons, toxins, degradation products of metabolism. The pronounced vollemic effect positively affects hemodynamics and is simultaneously accompanied by the washing out of metabolic products from the tissues, which together with an increase in diuresis provides an accelerated detoxification of the organism.

    With a rapid introduction, the plasma volume can be increased by a factor of 2 compared with the volume of the injected drug, each gram of a glucose polymer with a mole. with a mass of 30-40 thousand Dbut promotes the redistribution of 20-25 ml of fluid from tissues into the bloodstream. It is pyrogen-free, non-toxic.
    Pharmacokinetics:

    The half-life of the drug is 6 hours. Excretion by the kidneys, 60% is deduced in 6 hours, and 70% in 24 hours, 30% in the liver, where the enzyme is digested with acidic alpha-glucosidase to glucose, but it is not a source of carbohydrate nutrition.

    Indications:

    To improve capillary blood flow and replenish the volume of circulating blood:

    - traumatic, burn, hemorrhagic, postoperative, cardiogenic and toxic shock (prevention and treatment);

    - Substitution of plasma volume for blood loss in pediatrics;

    - to improve arterial and venous circulation (prevention and treatment): thrombosis, thrombophlebitis, obliterating endarteritis, Raynaud's disease;

    - to improve microcirculation and reduce the risk of thrombus formation in the graft in vascular and plastic surgery;

    - for detoxification: peritonitis, pancreatitis, ulcerative-necrotic enterocolitis, food toxic infections, extensive purulent-necrotic processes of soft tissues, crash syndrome, "inclusion" syndrome;

    - for hemodilution in the preoperative period;

    - Conducting therapeutic plasmapheresis in order to replace the removed volume of plasma;

    - to be added to the perfusion fluid in the cardiopulmonary bypass in cardiac surgery;

    - diseases of the retina and optic nerve (complicated high degree myopathy, dystrophy of the retina, vascular (venous) retinal pathology, initial atrophy), inflammatory diseases of the cornea and the choroid of the eye.

    Contraindications:

    Hypersensitivity, thrombocytopenia, chronic renal failure (anuria), chronic heart failure, and other conditions in which the introduction of large volumes of fluid is contraindicated.

    Electrophoresis is contraindicated in the maceration of the skin of the eyelids, abundant mucoid-purulent discharge.

    Pregnancy and lactation:Data on the efficacy and safety of the drug during pregnancy and lactation are not provided.
    Dosing and Administration:

    Individual, determined by the patient's condition, the value of blood pressure, heart rate, hematocrit.

    Intravenous, jet, drip-drop and drip.Doses and the speed of administration of the drug should be selected individually in accordance with the indications and condition of the patient.

    Immediately before the use of the drug, with the exception of urgent cases, cutaneous test. To do this, after treatment with ethanol at the injection site in the middle of the inner surface of the forearm, 0.05 ml is injected into the forearm to form a lemon crust. The presence of redness with a diameter of more than 1.5 mm at the injection site, the formation of a papule or the appearance of symptoms of a general reaction of the body in the form of nausea, dizziness, and other manifestations 10-15 min after injection indicate a hypersensitivity of the patient to the drug (risk group).

    When using the drug is mandatory bioassays: after slow administration of the first 5 drops of the drug, the transfusion is stopped for 3 minutes, then another 30 drops are added and the infusion is stopped again for 3 minutes. In the absence of a reaction, the administration of the drug continues. The results of the bioassay are necessarily recorded in the medical history.

    1. When there is a violation of capillary blood flow (various forms of shock) injected intravenously drip or drip-drop, at a dose of 0.5 to 1.5 liters, until the hemodynamic parameters stabilize.If necessary, the amount of the drug can be increased to 2 liters.

    Children with various forms of shock are administered at the rate of 5-10 ml / kg, the dose can be increased if necessary to 15 ml / kg. It is not recommended to reduce the hematocrit value below 25%.

    2. With cardiovascular and plastic operations injected intravenously drastically, immediately before surgery, for 30-60 minutes adults and children at a dose of 10 ml / kg, during surgery, adults - 500 ml, children - 15 ml / kg. After the operation, the drug is administered intravenously drip (within 60 minutes) for 5-6 days at the rate of: adults - 10 ml / kg, once for children up to 2-3 years - 10 ml / kg 1 time per day, children up to 8 years of age 7-10 ml / kg 1-2 times a day, children under 13 years - 5-7 ml / kg 1-2 times a day. For children older than 14 years, the doses are the same as for adults.

    3. In operations with artificial circulation the drug is added to the blood at a rate of 10-20 ml / kg of the patient to fill the oxygenator pump. The concentration of dextran in the perfusion solution should not exceed 3%. In the postoperative period, the doses of the drug are the same as for a violation of capillary blood flow.

    4. With the aim of detoxification injected intravenously drip in a single dose of 500 to 1250 ml (in children 5-10 ml / kg) for 60-90 minutes.If necessary, you can pour another 500 ml of the drug in the first day (in children the administration of the drug in the first day can be repeated in the same doses). In the following days, the drug is administered drip, adults in a daily dose of 500 ml, children - at a rate of 5-10 ml / kg.

    It is jointly advisable to introduce crystalloid solutions (Ringer and Ringer-acetate, etc.) in such quantities that normalize the water-electrolyte balance (especially important in the treatment of dehydrated patients and after surgery), the drug usually causes an increase in diuresis (a decrease in diuresis indicates for dehydration of the patient's body).

    5. In ophthalmic practice is applied by electrophoresis, which is carried out in a conventional manner. The drug consumption per procedure is 10 ml. The procedure is carried out once a day, injected from both the positive and negative pole. The current density is up to 1.5 mA / cm2.

    The duration of the procedure is 15-20 min. The course of treatment consists of 5-10 procedures.

    Side effects:

    Allergic reactions, anaphylactic reactions are possible with the development of collapse.

    Can provoke bleeding, the development of acute renal failure.

    Interaction:

    It is allowed to use together with other traditional transfusion means. It is necessary to first check the compatibility of dextran with drugs that are planned to enter into the infusion solution.

    Aminocaproic acid, hydralazine, warfarin, ethanol 95%, dexamethasone and some other medicines are incompatible with dextran.

    Special instructions:

    Together with the drug, it is advisable to administer crystalloid solutions (0.9% pacTop NaCl, 5% dextrose solution) in such quantity as to replenish and maintain the liquid and electrolyte balance. This is especially important in the treatment of dehydrated patients and after severe surgical operations.

    Causes an increase in diuresis (if there is a decrease in diuresis with the release of viscous syrupy urine, this may indicate dehydration). In this case, it is necessary to introduce intravenous colloidal solutions to replenish and maintain the water-electrolyte balance.

    In patients with a reduced filtration ability of the kidneys, it is necessary to limit the administration of NaCl.

    Dextrans are able to envelop the surface of red blood cells, preventing the determination of the blood group, so it is necessary to use washed red blood cells.

    Effect on the ability to drive transp. cf. and fur:

    Negative effect of the drug on the performance of potentially hazardous activities requiring special attention and quick reactions (driving, other vehicles, working with driving mechanisms, dispatcher and operator work, etc.) was not observed.

    Form release / dosage:Solution for infusion.
    Packaging:

    100, 200 or 400 ml in glass bottles for blood, infusion and transfusion preparations with a capacity of 100, 250 or 450 ml, respectively, corked with rubber stoppers and crimped with aluminum caps. A label of paper label or coated is glued on the bottle. Each bottle, together with the instruction for use, is placed in a pack of cardboard for consumer containers.

    56 bottles with a capacity of 100 ml, 24, 28 bottles with a capacity of 250 ml or 12, 15 bottles with a capacity of 450 ml respectively are placed in boxes of corrugated with an attachment instructions for use in an amount corresponding to the number of bottles.

    100, 200, 250, 400, 500 and 1000 ml into bags of polyolefin film.

    For each package, a self-adhesive label is applied or the label text is applied to the package by hot stamping, using thermal printing.

    56 bags of 100 ml, 24, 28 bags of 200 ml or 250 ml, 12, 15 bags of 400 ml or 500 ml, 12 1000 ml packets are placed in boxes of corrugated cardboard along with instructions for use in an amount corresponding to the number of packages .

    Storage conditions:

    In a dry place, at a temperature of 10 to 25 ° C.

    Shelf life:

    5 years.

    After the expiry date, the drug should not be used.

    Terms of leave from pharmacies:On prescription
    Registration number:LS-001517
    Date of registration:31.08.2011 / 13.10.2015
    The owner of the registration certificate:Promomed Rus, Open CompanyPromomed Rus, Open Company Russia
    Manufacturer: & nbsp
    Representation: & nbspBIOCHEMICAL JSC BIOCHEMICAL JSC Russia
    Information update date: & nbsp10.01.2016
    Illustrated instructions
      Instructions
      Up